New opinion

In re: Avandia Marketing — civil — affirmance — Roth

In an interlocutory appeal arising out of class action litigation over the diabetes drug Avandia, the Third Circuit today affirmed a district court ruling that the plaintiffs adequately alleged standing and proximate causation for their RICO claims against GlaxoSmithKline.

Joining Roth were Ambro and Scirica. Arguing counsel were  John Beisner of Skadden Arps for GSK and Samuel Issacharoff for the plaintiffs. The case was argued over 11 months ago.